Sign in

CIK 0001534248

  • Non-accelerated filer
  • Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
EIN
813676773
Phone
+972 773310156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,516
in 1 filing

Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohen Neil Harris −$7K Director sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2022-03-16 Marvin Donald Executive VP, CFO & COO Purchase +250 $3.30 $825 1,750
2022-03-16 Marvin Donald Executive VP, CFO & COO Purchase +250 $3.25 $813 2,000
2022-03-14 Marvin Donald Executive VP, CFO & COO Purchase +250 $4.00 $1K 250
2022-03-14 Marvin Donald Executive VP, CFO & COO Purchase +250 $3.98 $995 500
2022-03-14 Marvin Donald Executive VP, CFO & COO Purchase +250 $3.90 $975 1,000
2022-03-14 Marvin Donald Executive VP, CFO & COO Purchase +250 $4.10 $1K 1,250
2022-03-14 Marvin Donald Executive VP, CFO & COO Purchase +250 $4.20 $1K 1,500
2021-11-08 Marvin Donald Executive VP, CFO & COO Grant or award · Option to Purchase American Depositary Shares +196,875 196,875
2021-11-08 Marvin Donald Executive VP, CFO & COO Grant or award · Option to Purchase American Depositary Shares +196,875 196,875

Page 1 of 1 · 9 trades